Table 2.
Group A | Group B | p Value | |
---|---|---|---|
Hypoxia | |||
Hypoxia under deep sedation | 7 (15%) | 0 (0%) | 0.007 |
Respiratory support with an oropharyngeal airway | 7 (15%) | 1 (2%) | 0.025 |
Mechanical respiratory support | 2 (4%) | 0 (0%) | 0.159 |
Non-invasive positive pressure ventilations | 1 (2%) | 0 (0%) | 0.322 |
Endotracheal intubation | 1 (2%) | 0 (0%) | 0.322 |
Hypotension | |||
Hypotension under deep sedation | 13 (27%) | 11 (22%) | 0.528 |
Catecholamine use for hypotension | 0 (0%) | 1 (2%) | 0.322 |
Procedure time and dislocation of the 3D maps | |||
Time α (min) | 77±3 | 78±2 | 0.816 |
Time β (min) | 84±4 | 67±3 | 0.001 |
X-ray time (min) | 53±2 | 34±2 | <0.001 |
Dislocation of the 3D maps | 15 (31%) | 4 (8%) | 0.003 |
Complications associated with the procedures | |||
Cardiac tamponade | 1 (2%) | 1 (2%) | 0.966 |
Nasal bleeding | 12 (25%) | 0 (0%) | <0.001 |
Other complications associated with the procedures | 0 (0%) | 0 (0%) | NA |
Adverse events with insertion of oropharyngeal airways | 1 (2%) | NA | NA |
Adverse events with insertion of SGAs | NA | 0 (0%) | NA |
Time α=duration from admission to the catheterization room to starting the radiofrequency energy delivery, Time β=duration from starting the radiofrequency energy delivery to completion of the pulmonary vein antrum isolation, NA=not applicable. SGAs= supraglottic airways.